- Previous Close
592.75 - Open
592.13 - Bid 587.90 x 1000
- Ask 597.07 x 900
- Day's Range
588.44 - 596.13 - 52 Week Range
436.38 - 607.94 - Volume
1,896,094 - Avg. Volume
3,354,359 - Market Cap (intraday)
545.925B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
39.07 - EPS (TTM)
15.13 - Earnings Date Oct 15, 2024
- Forward Dividend & Yield 8.40 (1.42%)
- Ex-Dividend Date Sep 16, 2024
- 1y Target Est
623.61
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
www.unitedhealthgroup.com440,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: UNH
View MorePerformance Overview: UNH
Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UNH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UNH
View MoreValuation Measures
Market Cap
545.92B
Enterprise Value
589.70B
Trailing P/E
39.13
Forward P/E
18.94
PEG Ratio (5yr expected)
1.49
Price/Sales (ttm)
1.44
Price/Book (mrq)
6.11
Enterprise Value/Revenue
1.55
Enterprise Value/EBITDA
21.28
Financial Highlights
Profitability and Income Statement
Profit Margin
3.66%
Return on Assets (ttm)
7.07%
Return on Equity (ttm)
15.58%
Revenue (ttm)
385.44B
Net Income Avi to Common (ttm)
14.1B
Diluted EPS (ttm)
15.13
Balance Sheet and Cash Flow
Total Cash (mrq)
31.32B
Total Debt/Equity (mrq)
75.68%
Levered Free Cash Flow (ttm)
-11.78B
Research Analysis: UNH
View MoreCompany Insights: UNH
UNH does not have Company Insights
Research Reports: UNH
View MoreWhile the Election Looms, Near-Term Regulatory Risks Look Manageable for Managed-Care Organizations
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 50 million members globally, including 1 million outside the US as June 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
RatingPrice TargetArgus Quick Note: Weekly Stock List for 07/29/2024: AI Spotlight on Healthcare
Artificial intelligence (AI) has become a pervasive technology in the Healthcare sector. Companies have been adopting AI in medical imaging, drug discovery, documentation, and administration. In medical imaging and diagnostics, AI is advancing rapidly in the detection of tumors, infections, and fractures. In drug discovery, vast data sets are being used to identify potential drugs to treat disease and predict their efficacy. AI also can improve trial design and create treatments for a wider range of people, including those with rare diseases. The technology also has helped to create more-efficient methods for documenting medical information with Automatic Speech Recognition (ASR). ASR enables voice-to-text technology and increases the productivity of medical staff by nearly 10%. For administrative tasks, AI has streamlined billing, scheduling, and fraud detection (a major issue that raises medical expenses for consumers). Here is a list of Argus BUY-rated Healthcare stocks that are leaders in the use of AI.
Argus Quick Note: Weekly Stock List for 07/22/2024: Dividend Growers
Dividend income is often overlooked amid gyrations in the stock market. But dividends are an important element of return. Dividend income accounted for 42% of the total return of the S&P 500 between 1930 and 2012, according to Hartford Funds. And that's just the average. In some of those decades, dividends accounted for more than 50% of total returns and even 100% of returns. More recently, dividends have accounted for a smaller portion of returns, at around 15%-20%. Not for nothing, in 2022, dividend payments softened the blow when most market indices turned bearish as the Federal Reserve hiked interest rates. Not all dividends are created equal, though, and it is important to understand the difference between the two main categories: high-yield stocks and dividend-growth stocks. High-yield stocks typically have dividends that pay out in the 5%-8% range. Though the income appears attractive, the share prices of high-yield stocks could signal some risks. Dividend-growth stocks typically have lower yields, often in the 1.0%-2.5% range. But the lower-yielding dividends are not likely to be a huge component of cash flow, leaving management teams with other value-additive options for deploying cash -- such as share buybacks, M&A, the repayment of debt, or reinvestment in the core business. Below is a partial list of Argus BUY-rated stocks that are included in our June Dividend Growth Theme Model Portfolio.
Daily – Vickers Top Buyers & Sellers for 07/22/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.